RN7SL614P

Across TCGA pan-cancer cohorts, RN7SL614P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL614P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL614P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL614P is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

HNSC, STAD, and THCA are the cancer types where RN7SL614P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL614P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.109	.010	6	view →
STAD	All	All	+0.366	.014	4	view →
THCA	Female	II,III,IV	−0.340	<.001	3	view →
CHOL	Female	All	+0.310	<.001	1	view →
LUSC	Male	II,III,IV	−0.232	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL614P–HNSC

Open the HNSC breakdown →